APA (7th ed.) Citation

Pan, C., Han, P., Ji, Q., Li, C., Lu, J., Yang, J., . . . Chan, J. (2017). Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong. Journal of Diabetes, 9(4), 386. https://doi.org/10.1111/1753-0407.12425

Chicago Style (17th ed.) Citation

Pan, Changyu, et al. "Efficacy and Safety of Alogliptin in Patients with Type 2 Diabetes Mellitus: A Multicentre Randomized Double-blind Placebo-controlled Phase 3 Study in Mainland China, Taiwan, and Hong Kong." Journal of Diabetes 9, no. 4 (2017): 386. https://doi.org/10.1111/1753-0407.12425.

MLA (9th ed.) Citation

Pan, Changyu, et al. "Efficacy and Safety of Alogliptin in Patients with Type 2 Diabetes Mellitus: A Multicentre Randomized Double-blind Placebo-controlled Phase 3 Study in Mainland China, Taiwan, and Hong Kong." Journal of Diabetes, vol. 9, no. 4, 2017, p. 386, https://doi.org/10.1111/1753-0407.12425.